Vivo Bio Tech Ltd — Updates, 08-04-2025: Company Update

Vivo Bio Tech Limited has announced a board meeting for the allotment of 3,11,111 equity shares, converting warrants issued on a preferential basis to Kompella Ramakrishna Paramahamsa from the promoter group. Each share is priced at Rs. 45, with a premium of Rs. 35, resulting in total application money received of Rs. 1.05 crore. This increase raises the company's issued and subscribed share capital to Rs. 17.48 crore, underpinning financial resilience. The move could reflect strategic positioning for future growth, offering a positive outlook as it fortifies the equity base while enhancing investor confidence.